Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Harrow (HROW) over the last 7 years, with Q3 2025 value amounting to $208000.0.

  • Harrow's Asset Writedowns and Impairment rose 17368.42% to $208000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $688000.0, marking a year-over-year increase of 18196.72%. This contributed to the annual value of $120000.0 for FY2024, which is 6385.54% down from last year.
  • Per Harrow's latest filing, its Asset Writedowns and Impairment stood at $208000.0 for Q3 2025, which was up 17368.42% from $226000.0 recorded in Q2 2025.
  • Harrow's 5-year Asset Writedowns and Impairment high stood at $264000.0 for Q4 2023, and its period low was -$85000.0 during Q1 2024.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $19500.0 (2021), whereas its average is $62000.0.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first skyrocketed by 460000.0% in 2022, then crashed by 52500.0% in 2024.
  • Quarter analysis of 5 years shows Harrow's Asset Writedowns and Impairment stood at -$1000.0 in 2021, then skyrocketed by 4600.0% to $45000.0 in 2022, then surged by 486.67% to $264000.0 in 2023, then tumbled by 46.97% to $140000.0 in 2024, then surged by 48.57% to $208000.0 in 2025.
  • Its Asset Writedowns and Impairment was $208000.0 in Q3 2025, compared to $226000.0 in Q2 2025 and $114000.0 in Q1 2025.